Turtle Cameron: insider trades.
Turtle Cameron reported 12 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 12 sales ($4.1M), across 1 company.
- Transactions
- 12
- Purchases (P)
- 0
- Sales (S)
- 12
- Companies
- 1
- Name as filed
- Turtle Cameron
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | Director, Officer · Chief Executive Officer | 12 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-01 | Spyre Therapeutics, Inc. | S | 8,400 | $87.15 | 556,640 | Form 4 |
| 2026-09-01 | Spyre Therapeutics, Inc. | S | 2,500 | $86.36 | 565,040 | Form 4 |
| 2026-09-01 | Spyre Therapeutics, Inc. | S | 400 | $89.07 | 552,540 | Form 4 |
| 2026-09-01 | Spyre Therapeutics, Inc. | S | 3,700 | $88.06 | 552,940 | Form 4 |
| 2026-08-03 | Spyre Therapeutics, Inc. | S | 800 | $93.97 | 581,740 | Form 4 |
| 2026-08-03 | Spyre Therapeutics, Inc. | S | 7,157 | $95.1 | 574,583 | Form 4 |
| 2026-08-03 | Spyre Therapeutics, Inc. | S | 5,635 | $95.93 | 568,948 | Form 4 |
| 2026-08-03 | Spyre Therapeutics, Inc. | S | 1,392 | $96.82 | 567,556 | Form 4 |
| 2026-08-03 | Spyre Therapeutics, Inc. | S | 16 | $97.46 | 567,540 | Form 4 |
| 2026-07-01 | Spyre Therapeutics, Inc. | S | 4,234 | $88.12 | 583,130 | Form 4 |
| 2026-07-01 | Spyre Therapeutics, Inc. | S | 590 | $88.91 | 582,540 | Form 4 |
| 2026-07-01 | Spyre Therapeutics, Inc. | S | 10,176 | $87.44 | 587,364 | Form 4 |
Questions
What stock did Turtle Cameron buy or sell?
Turtle Cameron reported 12 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 12 sales ($4.1M), across 1 company.
Is Turtle Cameron the same person as other filers with this name?
This page covers SEC CIK 1758363 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/turtle-cameron-1758363.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.